Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Erratum: Lkb1 inactivation drives lung cancer lineage switching governed by Polycomb Repressive Complex 2.

Zhang H, Brainson CF, Koyama S, Redig AJ, Chen T, Li S, Gupta M, Garcia-de-Alba C, Paschini M, Herter-Sprie GS, Lu G, Zhang X, Marsh BP, Tuminello SJ, Xu C, Chen Z, Wang X, Akbay EA, Zheng M, Palakurthi S, Sholl LM, Rustgi AK, Kwiatkowski DJ, Alan Diehl J, Bass AJ, Sharpless NE, Dranoff G, Hammerman PS, Ji H, Bardeesy N, Saur D, Watanabe H, Kim CF, Wong KK.

Nat Commun. 2017 Jun 9;8:15901. doi: 10.1038/ncomms15901.

2.

Erratum.

[No authors listed]

Sci Technol Adv Mater. 2016 Apr 19;17(1):188. eCollection 2016.

3.

Spreading of X chromosome inactivation via a hierarchy of defined Polycomb stations.

Pinter SF, Sadreyev RI, Yildirim E, Jeon Y, Ohsumi TK, Borowsky M, Lee JT.

Genome Res. 2012 Oct;22(10):1864-76. doi: 10.1101/gr.133751.111. Epub 2012 Sep 4.

4.

PRC2 specifies ectoderm lineages and maintains pluripotency in primed but not naïve ESCs.

Shan Y, Liang Z, Xing Q, Zhang T, Wang B, Tian S, Huang W, Zhang Y, Yao J, Zhu Y, Huang K, Liu Y, Wang X, Chen Q, Zhang J, Shang B, Li S, Shi X, Liao B, Zhang C, Lai K, Zhong X, Shu X, Wang J, Yao H, Chen J, Pei D, Pan G.

Nat Commun. 2017 Sep 22;8(1):672. doi: 10.1038/s41467-017-00668-4.

5.

Erratum: Seven papers on fused-ring heterocyclic ketones containing an N-tosyl-pyrrolo-[3,4-c]pyrano moiety. Corrigenda.

Chinnakali K, Jayagobi M, Fun HK.

Acta Crystallogr Sect E Struct Rep Online. 2007 Dec 12;64(Pt 1):e11. doi: 10.1107/S1600536807063817.

6.

KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.

Farcas AM, Blackledge NP, Sudbery I, Long HK, McGouran JF, Rose NR, Lee S, Sims D, Cerase A, Sheahan TW, Koseki H, Brockdorff N, Ponting CP, Kessler BM, Klose RJ.

Elife. 2012 Dec 18;1:e00205. doi: 10.7554/eLife.00205.

7.

The FBXL10/KDM2B scaffolding protein associates with novel polycomb repressive complex-1 to regulate adipogenesis.

Inagaki T, Iwasaki S, Matsumura Y, Kawamura T, Tanaka T, Abe Y, Yamasaki A, Tsurutani Y, Yoshida A, Chikaoka Y, Nakamura K, Magoori K, Nakaki R, Osborne TF, Fukami K, Aburatani H, Kodama T, Sakai J.

J Biol Chem. 2015 Feb 13;290(7):4163-77. doi: 10.1074/jbc.M114.626929. Epub 2014 Dec 22.

8.

Polycomb complexes in X chromosome inactivation.

Brockdorff N.

Philos Trans R Soc Lond B Biol Sci. 2017 Nov 5;372(1733). pii: 20170021. doi: 10.1098/rstb.2017.0021. Review.

9.

Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line.

Gal-Yam EN, Egger G, Iniguez L, Holster H, Einarsson S, Zhang X, Lin JC, Liang G, Jones PA, Tanay A.

Proc Natl Acad Sci U S A. 2008 Sep 2;105(35):12979-84. doi: 10.1073/pnas.0806437105. Epub 2008 Aug 27.

10.

The role of LKB1 in lung cancer.

Sanchez-Cespedes M.

Fam Cancer. 2011 Sep;10(3):447-53. doi: 10.1007/s10689-011-9443-0. Review.

PMID:
21516316
11.

Erratum.

[No authors listed]

Arq Bras Cir Dig. 2017 Apr-Jun;30(2):164. doi: 10.1590/0102-6720201700020020. English, Portuguese.

12.

Lkb1 deletion in murine B lymphocytes promotes cell death and cancer.

Souroullas GP, Fedoriw Y, Staudt LM, Sharpless NE.

Exp Hematol. 2017 Jul;51:63-70.e1. doi: 10.1016/j.exphem.2017.04.005. Epub 2017 Apr 21.

13.

LKB1 gene inactivation does not sensitize non-small cell lung cancer cells to mTOR inhibitors in vitro.

Xiao P, Sun LL, Wang J, Han RL, Ma Q, Zhong DS.

Acta Pharmacol Sin. 2015 Sep;36(9):1107-12. doi: 10.1038/aps.2015.19. Epub 2015 Jun 1.

14.

LKB1 modulates lung cancer differentiation and metastasis.

Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K, Kozlowski P, Torrice C, Wu MC, Shimamura T, Perera SA, Liang MC, Cai D, Naumov GN, Bao L, Contreras CM, Li D, Chen L, Krishnamurthy J, Koivunen J, Chirieac LR, Padera RF, Bronson RT, Lindeman NI, Christiani DC, Lin X, Shapiro GI, Jänne PA, Johnson BE, Meyerson M, Kwiatkowski DJ, Castrillon DH, Bardeesy N, Sharpless NE, Wong KK.

Nature. 2007 Aug 16;448(7155):807-10. Epub 2007 Aug 5.

PMID:
17676035
15.

Update on the role and therapeutic potential of polycomb repressive complexes in (biliary tract) cancer.

Neureiter D, Kiesslich T, Ritter M, Mayr C.

Expert Opin Ther Targets. 2018 Jan;22(1):1-3. doi: 10.1080/14728222.2018.1406923. Epub 2017 Nov 20. No abstract available.

PMID:
29148857
16.

Polycomb repressive complex 2 regulates normal development of the mouse heart.

He A, Ma Q, Cao J, von Gise A, Zhou P, Xie H, Zhang B, Hsing M, Christodoulou DC, Cahan P, Daley GQ, Kong SW, Orkin SH, Seidman CE, Seidman JG, Pu WT.

Circ Res. 2012 Feb 3;110(3):406-15. doi: 10.1161/CIRCRESAHA.111.252205. Epub 2011 Dec 8.

17.

linc-UBC1 physically associates with polycomb repressive complex 2 (PRC2) and acts as a negative prognostic factor for lymph node metastasis and survival in bladder cancer.

He W, Cai Q, Sun F, Zhong G, Wang P, Liu H, Luo J, Yu H, Huang J, Lin T.

Biochim Biophys Acta. 2013 Oct;1832(10):1528-37. doi: 10.1016/j.bbadis.2013.05.010. Epub 2013 May 18.

18.

Variant PRC1 complex-dependent H2A ubiquitylation drives PRC2 recruitment and polycomb domain formation.

Blackledge NP, Farcas AM, Kondo T, King HW, McGouran JF, Hanssen LL, Ito S, Cooper S, Kondo K, Koseki Y, Ishikura T, Long HK, Sheahan TW, Brockdorff N, Kessler BM, Koseki H, Klose RJ.

Cell. 2014 Jun 5;157(6):1445-59. doi: 10.1016/j.cell.2014.05.004. Epub 2014 May 22.

19.

BRG1 and LKB1: tales of two tumor suppressor genes on chromosome 19p and lung cancer.

Rodriguez-Nieto S, Sanchez-Cespedes M.

Carcinogenesis. 2009 Apr;30(4):547-54. doi: 10.1093/carcin/bgp035. Epub 2009 Jan 28. Review.

PMID:
19176640
20.

RYBP stimulates PRC1 to shape chromatin-based communication between Polycomb repressive complexes.

Rose NR, King HW, Blackledge NP, Fursova NA, Ember KJ, Fischer R, Kessler BM, Klose RJ.

Elife. 2016 Oct 5;5. pii: e18591. doi: 10.7554/eLife.18591.

Supplemental Content

Support Center